Neuropeptide S: New Less Stress Peptide
Now Available from Peptides International


A new peptide that plays a major role in regulating sleep and stress was recently discovered. This peptide has the potential to lead to a new class of drugs for treating sleep and anxiety disorders and attention deficit disorder. Neuropeptide S (NPS), first discovered in 2002 (patent WO 02-31145 A1), is thought to be an important modulator of wakefulness and anxiety.

Behavioral responses with increased alertness, suppressed sleep and controlled stress responses were noted recently noted in mouse studies.1 NPS is produced by previously unidentified neurons in a brain stem region known for regulating arousal and anxiety between locus coeruleus and Barrington’s nucleus in the rat brain. Further tests demonstrated that rats injected with NPS showed increased alertness and reduced slow-wave and REM sleep over untreated rats. Human NPS is a 20-amino acid residue peptide with an N-terminal Serine and is highly conserved among 6 species.

Human

SFRNGVGTGMKKTSFQRAKS

Chimpanzee

SFRNGVGTGMKKTSFRRAKS

Dog

SFRNGVGTGMKKTSFRRAKS

Rat

SFRNGVGSGVKKTSFRRAKQ

Mouse

SFRNGVGSGAKKTSFRRAKQ

Chicken

SFRNGVGSGIKKTSFRRAKS

NPS-expressing neurons are uniquely localized in an unidentified cluster of cells between locus coeruleus and Barrington’s nucleus in the rat brain. Human NPS induces mobilization of intracellular Ca2+ ions through the expressed human NPS receptor (ED50 = 9.4 nM). Synthetic NPS exerts the following functions upon i.c.v. administration: i) increased locomotor activity in mice (>0.1 nmol), ii) increased wakefulness in rats by reducing all sleep stages [REM, slow wave sleep stage 1 (SWS1), and SWS2] (>0.1 nmol), and iii) dose-dependent attenuation of anxiety-like behavior in mice. The exact mechanism is not yet understood and these functions might be mutually related through an arousal-promoting effect.

Since NPS is produced by previously unidentified neurons in a brain stem region known for regulating anxiety and arousal, it is expected this novel peptide will help unravel the mechanism of sleep disorders and anxiety.

1. Y.-L. Xu, R.K. Reinscheid, S. Huitron-Resendiz, S.D. Clark, Z. Wang, S.H. Lin, F.A. Brucher, J. Zeng, N.K. Ly, S.J. Henriksen, L. de Lecea, and O. Civelli, Neuron, 43, 487 (2004). (Original)

Neuropeptide S Manufactured by the Peptide Institute and Now Available from Peptides International

CODE

PRODUCT

QTY

USD

PNP-4425-v
NEW!

Neuropeptide S (Human)
NPS Human
H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-
Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-
Lys-Ser-OH
(M.W. 2187.53) C93H155N31O28S
Novel Modulator of Arousal and Anxiety

Y.-L. Xu, R.K. Reinscheid, S. Huitron-Resendiz, S.D. Clark, Z. Wang, S.H. Lin, F.A. Brucher, J. Zeng, N.K. Ly, S.J. Henriksen, L. de Lecea, and O. Civelli, Neuron, 43, 487 (2004). (Original)

0.5 mg vial

225

space

Please contact our technical sales specialists to discuss your project needs and for custom inquiries.

Please contact Peptides International for ordering information.
Peptides International, Inc.
PO Box 24658
Louisville, Kentucky 40224 USA
Phone: 502-266-8787 or 800-777-4779
Fax: 502-267-1FAX (1329)

Email:  peptides@pepnet.com

HOME  | Back to New Peptide Institute Products |  E-mail

Search Main Menu Email

Peptides International